Fevertree wins Jefferies backing as US growth accelerates

What Brokers Say Retail & Consumer Written by: Ephrem Joseph 10:15 Thu 10 Sep 2026 --> Disclaimer No investment advice About this content Editorial Standards & Policies Share article About this content × About Ephrem Joseph Ephrem began his journalistic journey at Proactive in June 2021. With a strong academic background in Information Technology, his expertise particularly lies in the field of Cyber Security, Management Information Systems and Computer Forensics. Before joining Proactive, Ephrem worked as a researcher and lecturer at a number of leading universities, including the University of Portsmouth's Institute of Criminal Justice Studies, the University of Winchester’s Institute of Policing, and Jain... Read more About the publisher Proactive financial news and online broadcast teams provide fast, accessible, informative and actionable business and finance news content to a global investment audience. All our content is produced independently by our experienced and qualified teams of news journalists. Proactive news team spans the world’s key finance and investing hubs with bureaus and studios in London, New York, Toronto, Vancouver, Sydney and Perth. We are experts in medium and small-cap markets, we also keep our community up to date with blue-chip companies, commodities and broader investment stories. This is content that excites and engages motivated private investors. The team delivers news and unique insights across the market including but not confined to: biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto and emerging digital and EV technologies. Use of technology Proactive has always been a forward looking and enthusiastic technology adopter. Our human content creators are equipped with many decades of valuable expertise and experience. The team also has access to and use technologies to assist and enhance workflows. Proactive will on occasion use automation and software tools, including generative AI. Nevertheless, all content published by Proactive is edited and authored by humans, in line with best practice in regard to content production and search engine optimisation. Fevertree Drinks ( AIM:FEVR ) View Price & Profile Fevertree wins Jefferies backing as US growth accelerates Last updated: 10:15 10 Sep 2026 BST, First published: 10:06 10 Sep 2026 BST Fevertree Drinks (AIM:FEVR) has retained the backing of Jefferies, which kept its 'buy' recommendation and 1,100p price target after first-half results pointed to stronger US momentum and improving earnings prospects. The broker viewed the results as early evidence that of the Group's partnership with Molson Coors is beginning to deliver, with US revenue growth reaching 11% at constant currency and sales momentum building as distribution, merchandising and marketing activity expands. First-half sales of £184.2 million came in slightly ahead of Jefferies’ £182.2 million forecast, while adjusted EBITDA of £20.1 million was also above its £19.5 million estimate. Jefferies left its 2026 sales forecast unchanged at £400.7 million and EBITDA at £50.1 million, but increased its 2026 EPS estimate by 3% and its 2027 forecast by around 5%, helped by progress with Fever-Tree’s share buyback. US growth remains the main attraction for the broker, with off-trade sales growth accelerating from 6% in the first quarter to 11% in the second and 16% so far in the third. Jefferies expects the Molson Coors partnership to support further growth through wider distribution and stronger execution, while local production should improve margins, inventory efficiency and cash generation over the medium term. The broker also highlighted Fever-Tree’s diversification beyond tonic, with non-tonic products now accounting for 47% of group sales. Continue reading